Cargando…

Integrating Ligand-Receptor Interactions and In Vitro Evolution for Streamlined Discovery of Artificial Nucleic Acid Ligands

To discover DNA ligands against a predetermined receptor protein complex, we introduce a comprehensive version of ligand-guided selection (LIGS). LIGS is, itself, a variant of systematic evolution of ligands by exponential enrichment (SELEX). Herein, we have optimized LIGS to identify higher affinit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zumrut, Hasan E., Batool, Sana, Argyropoulos, Kimon V., Williams, Nicole, Azad, Roksana, Mallikaratchy, Prabodhika R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606840/
https://www.ncbi.nlm.nih.gov/pubmed/31255977
http://dx.doi.org/10.1016/j.omtn.2019.05.015
_version_ 1783431981509378048
author Zumrut, Hasan E.
Batool, Sana
Argyropoulos, Kimon V.
Williams, Nicole
Azad, Roksana
Mallikaratchy, Prabodhika R.
author_facet Zumrut, Hasan E.
Batool, Sana
Argyropoulos, Kimon V.
Williams, Nicole
Azad, Roksana
Mallikaratchy, Prabodhika R.
author_sort Zumrut, Hasan E.
collection PubMed
description To discover DNA ligands against a predetermined receptor protein complex, we introduce a comprehensive version of ligand-guided selection (LIGS). LIGS is, itself, a variant of systematic evolution of ligands by exponential enrichment (SELEX). Herein, we have optimized LIGS to identify higher affinity aptamers with high specificity. In addition, we demonstrate the expandability of LIGS by performing specific aptamer elution at 25°C, utilizing multiple monoclonal antibodies (mAbs) against cultured cells and primary cells obtained from human donors expressing the same receptor. Eluted LIGS libraries obtained through Illumina high-throughput (HT) DNA sequencing were analyzed by bioinformatics tools to discover five DNA aptamers with apparent affinities ranging from 3.06 ± 0.485 nM to 325 ± 62.7 nM against the target, T cell receptor-cluster of differentiation epsilon (TCR-CD3ε) expressed on human T cells. The specificity of the aptamers was validated utilizing multiple strategies, including competitive binding analysis and a double-knockout Jurkat cell line generated by CRISPR technology. The cross-competition experiments using labeled and unlabeled aptamers revealed that all five aptamers compete for the same binding site. Collectively, the data in this report introduce a modified LIGS strategy as a universal platform to identify highly specific multiple aptamers toward multi-component receptor proteins in their native state without changing the cell-surface landscape.
format Online
Article
Text
id pubmed-6606840
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Society of Gene & Cell Therapy
record_format MEDLINE/PubMed
spelling pubmed-66068402019-07-15 Integrating Ligand-Receptor Interactions and In Vitro Evolution for Streamlined Discovery of Artificial Nucleic Acid Ligands Zumrut, Hasan E. Batool, Sana Argyropoulos, Kimon V. Williams, Nicole Azad, Roksana Mallikaratchy, Prabodhika R. Mol Ther Nucleic Acids Article To discover DNA ligands against a predetermined receptor protein complex, we introduce a comprehensive version of ligand-guided selection (LIGS). LIGS is, itself, a variant of systematic evolution of ligands by exponential enrichment (SELEX). Herein, we have optimized LIGS to identify higher affinity aptamers with high specificity. In addition, we demonstrate the expandability of LIGS by performing specific aptamer elution at 25°C, utilizing multiple monoclonal antibodies (mAbs) against cultured cells and primary cells obtained from human donors expressing the same receptor. Eluted LIGS libraries obtained through Illumina high-throughput (HT) DNA sequencing were analyzed by bioinformatics tools to discover five DNA aptamers with apparent affinities ranging from 3.06 ± 0.485 nM to 325 ± 62.7 nM against the target, T cell receptor-cluster of differentiation epsilon (TCR-CD3ε) expressed on human T cells. The specificity of the aptamers was validated utilizing multiple strategies, including competitive binding analysis and a double-knockout Jurkat cell line generated by CRISPR technology. The cross-competition experiments using labeled and unlabeled aptamers revealed that all five aptamers compete for the same binding site. Collectively, the data in this report introduce a modified LIGS strategy as a universal platform to identify highly specific multiple aptamers toward multi-component receptor proteins in their native state without changing the cell-surface landscape. American Society of Gene & Cell Therapy 2019-06-04 /pmc/articles/PMC6606840/ /pubmed/31255977 http://dx.doi.org/10.1016/j.omtn.2019.05.015 Text en © 2019 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Zumrut, Hasan E.
Batool, Sana
Argyropoulos, Kimon V.
Williams, Nicole
Azad, Roksana
Mallikaratchy, Prabodhika R.
Integrating Ligand-Receptor Interactions and In Vitro Evolution for Streamlined Discovery of Artificial Nucleic Acid Ligands
title Integrating Ligand-Receptor Interactions and In Vitro Evolution for Streamlined Discovery of Artificial Nucleic Acid Ligands
title_full Integrating Ligand-Receptor Interactions and In Vitro Evolution for Streamlined Discovery of Artificial Nucleic Acid Ligands
title_fullStr Integrating Ligand-Receptor Interactions and In Vitro Evolution for Streamlined Discovery of Artificial Nucleic Acid Ligands
title_full_unstemmed Integrating Ligand-Receptor Interactions and In Vitro Evolution for Streamlined Discovery of Artificial Nucleic Acid Ligands
title_short Integrating Ligand-Receptor Interactions and In Vitro Evolution for Streamlined Discovery of Artificial Nucleic Acid Ligands
title_sort integrating ligand-receptor interactions and in vitro evolution for streamlined discovery of artificial nucleic acid ligands
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606840/
https://www.ncbi.nlm.nih.gov/pubmed/31255977
http://dx.doi.org/10.1016/j.omtn.2019.05.015
work_keys_str_mv AT zumruthasane integratingligandreceptorinteractionsandinvitroevolutionforstreamlineddiscoveryofartificialnucleicacidligands
AT batoolsana integratingligandreceptorinteractionsandinvitroevolutionforstreamlineddiscoveryofartificialnucleicacidligands
AT argyropouloskimonv integratingligandreceptorinteractionsandinvitroevolutionforstreamlineddiscoveryofartificialnucleicacidligands
AT williamsnicole integratingligandreceptorinteractionsandinvitroevolutionforstreamlineddiscoveryofartificialnucleicacidligands
AT azadroksana integratingligandreceptorinteractionsandinvitroevolutionforstreamlineddiscoveryofartificialnucleicacidligands
AT mallikaratchyprabodhikar integratingligandreceptorinteractionsandinvitroevolutionforstreamlineddiscoveryofartificialnucleicacidligands